Amlodipine Bs., Dabigatran Etexilate Mesylate, Enalapril Maleate, Ezetimibe, Lercanidipine, Nebivolol, Rivaroxaban, Trimetazidine, Fluconazole, Itraconazole, Ketoconazole, Voriconazole, Bilastine, Cetirizine, Desloratadine, Levocetirizine

Product Description

Ultratech India Limited manufactures a wide range of API's. Please refer our complete product list at www.ultratechindia.com. 

Ultratech India Limited is a 30 year old transnational company specializing in the manufacturing of Active Pharmaceutical Ingredients (APIs) and a diverse range of branded generic Finished Dosage Forms (FDFs) at its cGMP certified state-of-the-art manufacturing facilities in India, with a global presence.
Ultratech manufactures approximately 60 APIs and its key products are Trimetazidine, Fluconazole, Salbutamol, Glibenclamide, Vardenafil, Sildenafil, Tadalafil, Formoterol, Salmeterol, Ezetimibe, Oseltamivir, Bilastine, Vonoprazan, Nebivolol, Gadobutrol, Tetraxetan, Gadoterate, Dabigatran, Solifenacin, Vigabatrin, Dorzolamide, Valganciclovir, and Rivaroxaban, Vortioxetine, Voriconazole, Brinzolamide, Montelukast, Duloxetine, Zonisamide and Rupatadine. 

Ultratech India Limited

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer
Specifications
  • Details
    Cardiovascular, Anti Fungal, Anti Allergy / Anti histaminic

  • Selling Points
    Anti-Allergens; Cardiovascular Health; International Approvals/Standards; Product Features; Quality Service; The company's branded generic FDF portfolio includes over 300 drugs across a variety of therapeutic segments, including Cardiology, Diabetology, Antibiotics, Analgesics, Antineoplastics, Respiratory, Anti-Malarial, Gynaecology, Paediatrics, Nutraceuticals, and Health Supplements. Its FDFs product portfolio spans conventional dosage forms such as tablets, capsules, and injections, as well as advanced delivery systems like Pressurized Metered Dose Inhalers (pMDIs) and Dry Powder Inhalers (DPIs).

    The company has state-of-the-art manufacturing infrastructure supported with a well-equipped R&D unit. 

    The company also offers CDMO (Contract Development and Manufacturing Organization) services, custom synthesis for small molecule drug substances, process development, and contract manufacturing for both Bulk APIs and Pharmaceutical Finished Dosage Forms.

  • Model
    API
  • Supplied from
    India
  • Measured In
    kilogram

Ultratech India Limited

  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
API Producer

More Products from Ultratech India Limited (4)

Ultratech India Limited resources (1)